The Effectiveness of Renalof® Compared to Kalkurenal® and Placebo

• Main Authors: Benny Kristyantoro, Sabilal Alif, Tarmono Djojodimedjo, Budiono
• Format: Article PeerReviewed
• Language: English; English; English
• Published: The Indonesian Urological Association 2012
• Subjects: R Medicine (General); RC870-923 Diseases of the genitourinary system. Urology; RD Surgery
• Online Access: http://repository.unair.ac.id/95438/1/The%20Effectiveness%20of%20Renalof.pdf; http://repository.unair.ac.id/95438/2/The%20Effectiveness%20of%20Renalof%20%C2%AE%20Compared%20to%20Kalkurenal%20%C2%AE%20and%20Placebo.pdf; http://repository.unair.ac.id/95438/6/The%20Effectiveness%20of%20Renalof%20%C2%AE%20Comp.pdf; http://repository.unair.ac.id/95438/; http://juri.urologi.or.id/juri/article/view/61; https://doi.org/10.32421/juri.v19i2.61
• Institution: Universitas Airlangga

Objective: To compare the effectiveness after administration of Renalof ® to Kalkurenal ® and placebo in patient with renal calculus. Material & Method: We analyzed 30 patient with renal calculi less than or equal to 20 mm (2 cm) between January 2011 and March 2011. Patients were divided into 3 groups. Nine patients were treated with placebo, 8 patients were treated with Kalkurenal ® and the last 13 patients were treated with Renalof ®. After 30 days, we analyzed calcium and uric acid excretion for 24 hours and measured the stone with plain abdominal film and renal ultrasound. Results: There were decreased in excretion of calcium and uric acid all of patients but not significant statistically (p > 0,05) and there were significant decreased on stone measurement in patient treated with Renalof ®. Conclusion: Renalof ® can be given as adjunct therapy for patient with renal calculi. Keywords: Calcium and uric acid excretion in urine 24 hours, stone measurement and stone surface area.